Icici Prudential Asset Management CO LTD Gilead Sciences, Inc. Transaction History

Icici Prudential Asset Management CO LTD

$924 Million
Q3 2024

A detailed history of Icici Prudential Asset Management CO LTD transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Icici Prudential Asset Management CO LTD holds 129,977 shares of GILD stock, worth $11.7 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

129,977

Previous 141,911 8.41%

Holding current value

$11.7 Million

Previous $9.74 Million 11.89%

% of portfolio

1.18%

Previous 1.17%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$66.59 - $83.99 $794,685 - $1 Million	-11,934 Reduced 8.41%	129,977 $10.9 Million
Q2 2024 Jul 22, 2024	BUY	$63.15 - $72.88 $428,346 - $494,345	6,783 Added 5.02%	141,911 $9.74 Million
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $1.96 Million - $2.39 Million	27,355 Added 25.38%	135,128 $9.9 Million
Q4 2023 Jan 19, 2024	SELL	$73.27 - $83.09 $1.06 Million - $1.21 Million	-14,514 Reduced 11.87%	107,773 $8.73 Million
Q3 2023 Nov 02, 2023	BUY	$73.94 - $80.67 $1.56 Million - $1.7 Million	21,106 Added 20.86%	122,287 $9.16 Million
Q2 2023 Jul 20, 2023	BUY	$76.01 - $86.7 $5.71 Million - $6.51 Million	75,096 Added 287.89%	101,181 $7.8 Million
Q1 2023 May 04, 2023	BUY	$77.31 - $88.08 $1.53 Million - $1.74 Million	19,786 Added 314.11%	26,085 $2.16 Million
Q4 2022 Feb 07, 2023	SELL	$62.32 - $89.47 $6.62 Million - $9.5 Million	-106,181 Reduced 94.4%	6,299 $540,000
Q3 2022 Oct 28, 2022	BUY	$59.54 - $68.01 $51,323 - $58,624	862 Added 0.77%	112,480 $6.94 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $7,849 - $8,841	136 Added 0.12%	111,618 $6.97 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $550,761 - $690,163	9,509 Added 9.33%	111,482 $6.65 Million
Q4 2021 Feb 08, 2022	BUY	$64.88 - $73.64 $200,868 - $227,989	3,096 Added 3.13%	101,973 $7.4 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $1.81 Million - $1.98 Million	28,563 Added 40.62%	98,877 $6.81 Million
Q1 2021 Apr 30, 2021	BUY	$60.0 - $68.46 $332,040 - $378,857	5,534 Added 8.54%	70,314 $4.61 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $3.22 Million - $3.67 Million	56,880 Added 720.0%	64,780 $3.77 Million
Q2 2017 Aug 11, 2017	BUY	N/A	7,900	7,900 $601 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Icici Prudential Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Icici Prudential Asset Management CO LTD with notifications on news.

Account

Icici Prudential Asset Management CO LTD Gilead Sciences, Inc. Transaction History